Literature DB >> 12880185

Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery.

S Alagna1, M L Cossu, A Masala, M M Atzeni, M Ruggiu, F M Satta, E Fais, P P Rovasio, G Noya.   

Abstract

Biliopancreatic diversion (BPD), a gastrectomy with a long ROUX en Y reconstruction, reduces intestinal absorption by delaying the mixing of food and biliopancreatic juices, and induces persistent weight loss in obese patients unresponsive to medical treatments. The levels of leptin (a plasma protein synthesised in human adipose tissue) are increased in obese subjects and significantly decrease after a major weight loss. A possible role of thyroid hormones in regulating adipose tissue metabolism in humans has been proposed, but it is not universally accepted and the relationship between thyroid function and leptin levels has not yet been clearly defined. We studied serum leptin, TSH, fT4 and fT3 levels in 38 obese patients (26 women and 12 men), before and 12 months after BPD. There was a significant post-surgical decrease in BMI and circulating leptin levels in all of the treated subjects, but thyroid function did not seem to be affected (TSH and fT4 levels were unchanged). However, fT3 levels significantly decreased after surgery. Our data suggest that BPD-induced malabsorption has no direct effect on thyroid function, but possibly reduces the peripheral conversion of thyroxine to T3. Further studies seem to be necessary to clarify the clinical relevance of these observations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880185     DOI: 10.1007/bf03324997

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  23 in total

1.  Radiommunological measurement of leptin in plasma of obese and diabetic human subjects.

Authors:  G P McGregor; J F Desaga; K Ehlenz; A Fischer; F Heese; A Hegele; C Lammer; C Peiser; R E Lang
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

2.  Influence of thyroid status on serum immunoreactive leptin levels.

Authors:  R Valcavi; M Zini; R Peino; F F Casanueva; C Dieguez
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

3.  Effect of fasting on serum leptin in normal human subjects.

Authors:  G Boden; X Chen; M Mozzoli; I Ryan
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

4.  Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects.

Authors:  J H Pinkney; S J Goodrick; J Katz; A B Johnson; S L Lightman; S W Coppack; V Mohamed-Ali
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

5.  The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects.

Authors:  T Zimmermann-Belsing; M Dreyer; J J Holst; U Feldt-Rasmussen
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

6.  Relationship between serum leptin and thyroid hormones in children.

Authors:  T Asami; T Ciomarten; M Uchiyama
Journal:  Pediatr Int       Date:  2000-06       Impact factor: 1.524

7.  Role of thyroid hormones on serum leptin levels.

Authors:  G Sesmilo; R Casamitjana; I Halperin; R Gomis; E Vilardell
Journal:  Eur J Endocrinol       Date:  1998-10       Impact factor: 6.664

8.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

Review 9.  Surgical treatment for morbid obesity.

Authors:  J Kolanowski
Journal:  Br Med Bull       Date:  1997       Impact factor: 4.291

Review 10.  Endocrine abnormalities of obesity.

Authors:  P Björntorp
Journal:  Metabolism       Date:  1995-09       Impact factor: 8.694

View more
  7 in total

Review 1.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters.

Authors:  Draženka Janković; Peter Wolf; Christian-Heinz Anderwald; Yvonne Winhofer; Miriam Promintzer-Schifferl; Astrid Hofer; Felix Langer; Gerhard Prager; Bernhard Ludvik; Alois Gessl; Anton Luger; Michael Krebs
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 3.  Effect of Bariatric Surgery on Thyroid Function in Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Bingsheng Guan; YanYa Chen; Jingge Yang; Wah Yang; Cunchuan Wang
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

4.  Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function.

Authors:  João Sérgio Neves; Sofia Castro Oliveira; Pedro Souteiro; Jorge Pedro; Daniela Magalhães; Vanessa Guerreiro; Rita Bettencourt-Silva; Maria Manuel Costa; Ana Cristina Santos; Joana Queirós; Ana Varela; Paula Freitas; Davide Carvalho
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

5.  Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion.

Authors:  Donatella Gniuli; Laura Leccesi; Caterina Guidone; Amerigo Iaconelli; Chiara Chiellini; Andrea Manto; Marco Castagneto; Giovanni Ghirlanda; Geltrude Mingrone
Journal:  Obes Surg       Date:  2009-11-03       Impact factor: 4.129

6.  Effect of sleeve gastrectomy on thyroid hormone levels.

Authors:  Yasmin Abu-Ghanem; Roy Inbar; Vitaly Tyomkin; Ilan Kent; Liron Berkovich; Ronen Ghinea; Shmuel Avital
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

7.  Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit.

Authors:  Lucyna Kozłowska; Danuta Rosołowska-Huszcz
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.